Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-19
2011-04-19
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S398000
Reexamination Certificate
active
07928132
ABSTRACT:
Methods of ameliorating episodes of accute or chronic colitis are provided by using methimazole derivatives and tautomeric cyclic thiones in combination with another pharmaceutical compound.
REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni et al.
patent: 3630200 (1971-12-01), Higuchi et al.
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4734421 (1988-03-01), Hammond et al.
patent: 5556574 (1996-09-01), Rivas et al.
patent: 6365616 (2002-04-01), Kohn et al.
patent: 2005/0209295 (2005-09-01), Kohn et al.
patent: 00/25756 (2000-05-01), None
The Merck Manual, 17thedition (1999), p. 307.
Isman et al., Journal of Endocrinology (2003), 177(3), 471-476.
The Merck Manual, 17thedition (1999), pp. 310-311.
Grisham, M. B., and D. N. Granger. 1999. Leukocyte-endothelial cell interactions in inflammatory bowel disease. In Inflammatory bowel disease. J. B. Kirsner, ed. Saunders, Philadelphia, p. 55-64.
Cario, E., and D. K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68:7010-7017.
Singh, U. P., S. Singh, D. D. Taub, and J. W. Lillard, Jr. 2003. Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10−/− mice. J Immunol 171:1401-1406.
Kobayashi M, Kweon MN, Kuwata H et al. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J Clin Invest 2003;111(9):1297-308.
Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules.Blood 84:2068-2101.
Luscinskas, F. W., and M. A. Gimbrone. 1996. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment.Annu. Rev. Med. 47:413-421.
Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.Cell 76:301-314.
Targan, S. R., S. B. Hanauer, S. J. van Deventer, L. Mayer, D. H. Present, T. Braakman, K. L. DeWoody, T. F. Schaible, and P. J. Rutgeerts. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.N Engl J Med 337:1029-1035.
Soriano, A., A. Salas, M. Sans, M. Gironella, M. Elena, D. C. Anderson, J. M. Pique, and J. Panes. 2000. VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS- induced colitis in mice.Lab. Invest. 80:1541-1551.
Wallace, J. L., A. Higa, G. W. McKnight, and D. E. MacIntyre. 1992. Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence.Inflammation 16:343-354.
Conner, E. M., S. Brand, J. M. Davis, F. S. Laroux, V. J. Palombella, J. W. Fuseler, D. Y. Kang, R. E. Wolf, and M. B. Grisham. 1997. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis.J Pharmacol Exp Ther 282:1615-1622.
Cooper, D. S. 1984. Antithyroid drugs.N Engl J Med 311:1353-1362.
Elias, A. N., R. J. Barr, M. K. Rohan, and K. Dangaran. 1995. Effect of orally administered antithyroid thioureylenes on PCNA and P53 expression in psoriatic lesions.Int J Dermatol 34:280-283.
Singer, D. S., L. D. Kohn, H. Zinger, and E. Mozes. 1994. Methimazole prevents induction of experimental systemic lupus erythematosus in mice.J Immunol 153:873-880.
Chan, C. C., I. Gery, L. D. Kohn, R. B. Nussenblatt, E. Mozes, and D. S. Singer. 1995. Periocular inflammation in mice with experimental systemic lupus erythematosus. A new experimental blepharitis and its modulation.J Immunol 154:4830-4835.
Davies, T. F., I. Weiss, and M. A. Gerber. 1984. Influence of methimazole on murine thyroiditis. Evidence for immunosuppression in vivo.J Clin Invest 73:397-404.
Wang, P., S. H. Sun, P. B. Silver, C. C. Chan, R. K. Agarwal, B. Wiggert, L. D. Kohn, G. A. Jamieson, Jr., and R. R. Caspi. 2003. Methimazole protects from experimental autoimmune uveitis (EAU) by inhibiting antigen presenting cell function and reducing antigen priming.J Leukoc Biol 73:57-64.
Wenisch, C., D. Myskiw, A. Gessl, and W. Graninger. 1995. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.J Clin Endocrinol Metab 80:2122-2126.
Oren, R., Y. Maaravi, F. Karmeli, G. Kenet, L. Zeidel, A. Hubert, and R. Eliakim. 1997. Anti-thyroid drugs decrease mucosal damage in a rat model of experimental colitis.Aliment Pharmacol Ther 11:341-345.
Dagia, N. M., N. Harii, A. E. Meli, X. Sun, C. J. Lewis, L. D. Kohn, and D. J. Goetz. 2004. Phenyl methimazole inhibits TNFα-induced VCAM-1 expression in an IFN Regulatory Factor-1-dependent manner and reduces monocytic cell adhesion to endothelial cells—J Immunol 173:2041-2049.
Lange, S., D. S. Delbro, E. Jennische, and I. Mattsby-Baltzer. 1996. The role of the Lps gene in experimental ulcerative colitis in mice.Apmis 104:823-833.
Takeda, K., and S. Akira. 2003. Toll receptors and pathogen resistance.Cell Microbiol 5:143-153.
Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors.Annu Rev Immunol 21:335-376.
Oshiumi, H., M. Matsumoto, K. Funami; T. Akazawa, and T. Seya. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.Nat Immunol 4:161-167.
Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.J Immunol 169:6668-6672.
Bendjelloul, F., P. Rossmann, P. Maly, V. Mandys, M. Jirkovska, L. Prokesova, L. Tuckova, and H. Tlaskalova-Hogenova. 2000. Detection of ICAM-1 in experimentally induced colitis of ICAM-1-deficient and wild-type mice: an immunohistochemical study.Histochem J 32:703-709.
Mabley, J. G., P. Pacher, L. Liaudet, F. G. Soriano, G. Hasko, A. Marton, C. Szabo, and A. L. Salzman. 2003. Inosine reduces inflammation and improves survival in a murine model of colitis.Am J Physiol Gastrointest Liver Physiol 284:G138-144.
Suzuki, K., A. Mori, K. J. Ishii, J. Saito, D. S. Singer, D. M. Klinman, P. R. Krause, and L. D. Kohn. 1999. Activation of target-tissue immune-recognition molecules by double- stranded polynucleotides.Proc Natl Acad Sci U S A 96:2285-2290.
Dieleman, L. A., M. J. Palmen, H. Akol, E. Bloemena, A. S. Pena, S. G. Meuwissen, and E. P. Van Rees. 1998. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.Clin Exp Immunol 114:385-391.
Tuvlin, J. A., and S. V. Kane. 2003. Novel therapies in the treatment of ulcerative colitis.Expert Opin Investig Drugs 12:483-490.
Pallone, F., V. Blanco Gdel, P. Vavassori, I. Monteleone, D. Fina, and G. Monteleone. 2003. Genetic and pathogenetic insights into inflammatory bowel disease.Curr Gastroenterol Rep 5:487-492.
Panes, J., and D. N. Granger. 1998. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease.Gastroenterology 114:1066-1090.
Ortega-Cava, C. F., S. Ishihara, M. A. Rumi, K. Kawashima, N. Ishimura, H. Kazumori, J. Udagawa, Y. Kadowaki, and Y. Kinoshita. 2003. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut.J Immunol 170:3977-3985.
Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis.Gastroenterology 115:182-205.
Kjellin and Sandstrom. Tautomeric Cyclic Thiones; Part II. Preparation of N- and S-Methyl Derivatives of Some Azoline-2-thiones. Acta Chemica Scandanavica 23: 2879-2887 (1969).
Szabo S.J et al. Molecular Mechanisms Regulating Th1 Immune Responses. Annu. Rev. Immunol. 2003. 21:713-58.
Benavides-Peralta Uruguaysito
Dagia Nilesh D.
Goetz Douglas J.
Gonzalez-Murguiondo Mariana
Harii Norikazu
McNichol William J.
Ohio University
Reed Smith LLP
Spivack Phyllis G.
LandOfFree
Methods for the amelioration of episodes of acute or chronic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the amelioration of episodes of acute or chronic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the amelioration of episodes of acute or chronic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2723075